[1] Zur HH.Papillomaviruses causing cancer:evasion from host-cell control in early events in carcinogenesis[J].J Natl Cancer Inst,2000,92(9):690-698.
[2] Zhu Fangpei,Ren Qingling.New progress in early screening of cervical cancer and precancerous lesions [J].Modern Oncology,2016,24(12):149-152.[朱方培,任青玲.宫颈癌及癌前病变早期筛查的新进展[J].现代肿瘤医学,2016,24(12):149-152.]
[3] Jiang Shuqing,Tu Songai,Zhou Junlan,et al.Investigation and analysis of women's disease in Zuler county,Xinjiang[J].Chinese Maternal and Child Health,2006,21(4):524-526.[姜淑清,土送爱,周俊兰,等.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,21(4):524-526.]
[4] Husaiyin S,Niyazi M,Wang L,et al.HPV infection among Uygur women in a rural area of Hetian Prefecture,Xinjiang Uygur Autonomous Region,China[J].Biomed Environ Sci,2013,26(11):934-936.
[5] Wardak S.Human Papillomavirus (HPV) and cervical cancer[J].Med Dosw Mikrobiol,2016,68(1):73-84.
[6] Burd EM,Dean CL.Human papillomavirus[J].Microbiol Spectr,2016,4(4):3-5.
[7] Castellsagué X.Natural history and epidemiology of HPV infection and cervical cancer[J].Gynecologic Oncology,2008,110(3 Supplement 2):S4-S7.
[8] Nielsen A,Kjaer SK,Munk C,et al.Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women[J].J Med Virol,2010,82(4):616-623.
[9] Sui S,Zhu M,Jiao Z,et al.Prognosis and related factors of HPV infections in postmenopausal Uyghur women[J].J Obstet Gynaecol,2018:14(10):1-5.
[10] Gao Dongmei,Long Mei,Zhang Lu,et al.Study on HPV-DNA expression and presence in cervical cancer tissues of xinjiang uygur autonomous region [J].Journal of Xinjiang Medical University,2014,41(04):837-840.[高冬梅,龙梅,张璐,等.新疆维吾尔族宫颈癌组织中HPV-DNA表达及存在状态的研究[J].新疆医科大学学报,2014,41(04):837-840.]
[11] Ciotti M,Paba P,Bonifacio D,et al.Single or multiple HPV types in cervical cancer and associated metastases[J].Oncol Rep,2006,15(1):143-148.
[12] van der Weele P,van Logchem E,Wolffs P,et al.Correlation between viral load,multiplicity of infection,and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women[J].J Clin Virol,2016,83:6-11.
[13] Shi N,Lu Q,Zhang J,et al.Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus[J].Hum Vaccin Immunother,2017,13(6):1-7.
[14] Bae J,Seo SS,Park YS,et al.Natural history of persistent high-risk human papillomavirus infections in Korean women[J].Gynecol Oncol,2009,115(1):75-80.